Recurrence of previous chilblain lesions during the second wave of COVID-19: can we still doubt the correlation with SARS-CoV-2?

J Eur Acad Dermatol Venereol. 2021 Aug;35(8):e475-e477. doi: 10.1111/jdv.17283. Epub 2021 May 1.

S Signa^{1

2}, A R Sementa³, M C Coccia³, C Pastorino⁴, G Viglizzo⁴, S Viola⁵, S Volpi^{1

2}, C Occella⁴, D Bleidl⁴, M Acquila⁶, E Castagnola⁷, A Ravelli^{2

5}, F Manunza⁴

¹ UOSD Centro Malattie Autoinfiammatorie e Immunodeficienze, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
² Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili (DINOGMI), Università di Genova, Genoa, Italy.
³ UOC Anatomia Patologica, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
⁴ UOC Dermatologia, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
⁵ UOC Clinica Pediatrica e Reumatologia, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
⁶ UOC Laboratori Analisi, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
⁷ UOC Malattie Infettive, IRCCS Istituto Giannina Gaslini, Genoa, Italy.

No abstract available

Keywords: COVID-19; Chilblain; SARS-CoV2.

Publication types